Evidence map›Paper›PMID 41023259›Full record

ArticleMycopathologia2025

Optimization of the Genome Editing CRISPR-Cas9 Technology in Scedosporium apiospermum.

Kévin Ravenel, Wilfried Poirier, Bienvenue Razafimandimby, Jean-Philippe Bouchara, Amandine Gastebois, Sandrine Giraud

Abstract read
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kévin RavenelIRF (Infections Respiratoires Fongiques), Univ Angers, Univ Brest, SFR ICAT 4208, Angers, France.
Wilfried PoirierIRF (Infections Respiratoires Fongiques), Univ Angers, Univ Brest, SFR ICAT 4208, Angers, France.
Bienvenue RazafimandimbyIRF (Infections Respiratoires Fongiques), Univ Angers, Univ Brest, SFR ICAT 4208, Angers, France.
Jean-Philippe BoucharaIRF (Infections Respiratoires Fongiques), Univ Angers, Univ Brest, SFR ICAT 4208, Angers, France.
Amandine GasteboisIRF (Infections Respiratoires Fongiques), Univ Angers, Univ Brest, SFR ICAT 4208, Angers, France.
Sandrine GiraudIRF (Infections Respiratoires Fongiques), Univ Angers, Univ Brest, SFR ICAT 4208, Angers, France. sandrine.giraud@univ-angers.fr.ORCID http://orcid.org/0000-0002-3214-1719

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scedosporium species are opportunistic pathogens causing a large variety of human infections. To date, there is limited information on the pathogenic mechanisms of these fungi, partly because of the limited number of genetic tools available. Here, the CRISPR-Cas9 technology, which provided promising results for functional genomic studies in filamentous fungi, was optimized for Scedosporium species using in vitro assembled Cas9 ribonucleoprotein (RNP) complexes. In these fungi, functional genomic studies are particularly complex in a wild-type strain, because of the high frequency of non-homologous recombination. Prior disruption of the KU70 gene encoding one of the components of the non-homologous end joining system is required, which necessitates the use of a first selection marker. The cleavage of the target gene at each end using a dual RNA-guided Cas9 complex, followed by recombination with a repair template containing the hygromycin resistance gene, allowed disruption of the target gene in the ΔKU70 mutant. Four genes encoding dioxygenases, catalyzing the critical ring-opening step in aromatic hydrocarbons, were successfully disrupted, and the optimum efficiency was observed using 5 μg of the HygR repair cassette. Alternatively, in the wild-type strain, the exclusive use of two Cas9 RNP complexes was enough to achieve an efficient deletion method; one dioxygenase gene was successfully deleted in up to 20% of the obtained colonies. These last experimental conditions path the way to multiple gene deletions and complementation experiments, which cannot be reached using our first procedure since only two selection markers are available for Scedosporium species.

Indexed as

CRISPR-Cas SystemsGene EditingScedosporiumCRISPR-Cas9Fungal genome editingin vitro strategyOptimizationScedosporium apiospermum

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.